Votrient medication contains the active element pazopanib, which is a form of medicine known as a protein kinase inhibitor. Pazopanib functions by connecting to certain receptors on cancer cells and cells in blood vessel walls and blocking the action of the protein kinases. It works by interfering with the pathways that signal certain cancer cells to grow.